当前位置:首页 - 行情中心 - 福元医药(601089) - 财务分析

福元医药

(601089)

  

流通市值:32.65亿  总市值:76.32亿
流通股本:2.05亿   总股本:4.80亿

福元医药(601089)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润4.92亿元,每股收益1.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益355608.14万元,未分配利润137531.22万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产481663.24万元,负债126055.10万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入3,445,642,486.392,547,022,297.141,655,495,417.22802,722,388.57
营业总成本2,942,075,836.892,143,616,163.41,362,185,010.9671,053,272.62
营业利润542,528,607.88435,280,857.09319,042,294.69148,380,642.31
利润总额540,115,197.92433,303,595.87318,619,561.42148,027,971.25
净利润492,077,598.39404,081,251.12292,438,727.97133,524,586.6
其他综合收益----
综合收益总额492,077,598.39404,081,251.12292,438,727.97133,524,586.6
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计3,201,162,514.773,118,552,756.373,090,659,828.553,207,420,793.26
非流动资产合计1,615,469,870.291,418,101,246.711,346,177,998.831,286,488,414.51
资产总计4,816,632,385.064,536,654,003.084,436,837,827.384,493,909,207.77
流动负债合计1,189,939,548.361,018,132,717.88987,179,334.85963,856,813.12
非流动负债合计70,611,449.250,416,383.5564,540,446.9168,796,569.82
负债合计1,260,550,997.561,068,549,101.431,051,719,781.761,032,653,382.94
归属于母公司股东权益合计3,544,556,038.13,456,850,886.683,375,177,940.943,452,185,860.68
股东权益合计3,556,081,387.53,468,104,901.653,385,118,045.623,461,255,824.83
负债和股东权益合计4,816,632,385.064,536,654,003.084,436,837,827.384,493,909,207.77
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计3,470,729,490.422,587,517,831.851,723,816,059.83863,597,324.97
经营活动现金流出小计2,779,977,895.52,097,513,437.781,377,582,240.81719,714,280.45
经营活动产生的现金流量净额690,751,594.92490,004,394.07346,233,819.02143,883,044.52
投资活动现金流入小计2,427,233,421.841,161,023,838.779,807,7428,571,117.5
投资活动现金流出小计4,441,823,822.162,729,547,410.291,242,818,231.6599,900,685.86
投资活动产生的现金流量净额-2,014,590,400.32-1,568,523,571.52-1,233,010,489.65-91,329,568.36
筹资活动现金流入小计49,900,00049,900,00049,900,00039,900,000
筹资活动现金流出小计516,801,755.03502,095,113452,930,887.65201,298,217.07
筹资活动产生的现金流量净额-466,901,755.03-452,195,113-403,030,887.65-161,398,217.07
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-1,790,740,560.43-1,530,714,290.45-1,289,807,558.28-108,844,740.91
期末现金及现金等价物余额713,759,803.65973,786,073.631,214,692,805.82,395,655,623.17
最新报告期:2025-03-31
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
太平洋周豫1.131.321.522025-03-31
TOP↑